Zobrazeno 1 - 10
of 121
pro vyhledávání: '"Jieon, Lee"'
Autor:
Ji-Youn Han, Myung-Ju Ahn, Ki Hyeong Lee, Yun-Gyoo Lee, Dong-Wan Kim, Young Joo Min, Sang-We Kim, Eun Kyung Cho, Joo-Hang Kim, Gyeong-Won Lee, Sung Sook Lee, Na Mi Lee, Hyun Woo Jang, Heewon Han, Hyejoo Park, Jieon Lee, Byoung Chul Cho
Publikováno v:
BMC Medicine, Vol 22, Iss 1, Pp 1-10 (2024)
Abstract Background Lazertinib is a potent, irreversible, third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) with significant efficacy in patients with EGFR T790M-mutated non-small cell lung cancer (NSCLC). This
Externí odkaz:
https://doaj.org/article/8bfcc4d65fa047f3a5990e84062ee6df
Autor:
Sangwoo Lee, Gun Tae Jung, Mina Cho, Jae Won Lee, Kojo Eghan, Jieon Lee, Seokjoo Yoon, Kwang Pyo Kim, Woo-Keun Kim
Publikováno v:
Ecotoxicology and Environmental Safety, Vol 262, Iss , Pp 115119- (2023)
Eicosanoids play important roles in inflammation, allergy, fever, and immune responses. In the eicosanoid pathway, cyclooxygenase (COX) catalyzes the conversion of arachidonic acid to prostaglandins and is a crucial target of nonsteroidal anti-inflam
Externí odkaz:
https://doaj.org/article/918844e64ad14671a7ce25236c93c7ac
Autor:
Yuqing Gong, Kairui Feng, Peijue Zhang, Jieon Lee, Yuzhuo Pan, Zhen Zhang, Zhanglin Ni, Tao Bai, Miyoung Yoon, Bing Li, Carol Y. Kim, Lanyan Fang, Liang Zhao
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology, Vol 11, Iss 7, Pp 833-842 (2022)
Abstract The coronavirus disease 2019 (COVID‐19) has presented unprecedented challenges to the generic drug development, including interruptions in bioequivalence (BE) studies. Per guidance published by the US Food and Drug Administration (FDA) dur
Externí odkaz:
https://doaj.org/article/1ec6f5c20dfb4d9b80e44279448a3006
Autor:
Hediye Nese Cinar, Gopal Gopinath, Helen R. Murphy, Sonia Almeria, Mauricio Durigan, Dajung Choi, AhYoung Jang, Eunje Kim, RaeYoung Kim, Seonju Choi, Jeongu Lee, Yurim Shin, Jieon Lee, Yvonne Qvarnstrom, Theresa K. Benedict, Henry S. Bishop, Alexandre da Silva
Publikováno v:
Parasites & Vectors, Vol 13, Iss 1, Pp 1-12 (2020)
Abstract Background Outbreaks of cyclosporiasis, a diarrheal illness caused by Cyclospora cayetanensis, have been a public health issue in the USA since the mid 1990’s. In 2018, 2299 domestically acquired cases of cyclosporiasis were reported in th
Externí odkaz:
https://doaj.org/article/15c8655047f6488898f6627c9754e497
Publikováno v:
Journal of Gynecologic Oncology. 2024 Supplement, Vol. 35, p58-59. 2p.
Autor:
Ga Young Park, Cheoul‐Hong Park, Sang Kwang Lee, Chun Young Im, Soong‐Hyun Kim, Hee Jong Hwang, Jieon Lee, Taeho Lee, Yong Rae Hong, Minsoo Song
Publikováno v:
Bulletin of the Korean Chemical Society. 44:202-207
Publikováno v:
International Journal of Human–Computer Interaction. :1-12
Publikováno v:
Proceedings of the Human Factors and Ergonomics Society Annual Meeting. 66:1678-1681
Electronic masks are wearable devices that can replace common disposable hygiene masks. Understanding user discomfort is important for proper electronic mask evaluation and design, but the method has not been standardized yet. This study presents eva
Publikováno v:
Molecules, Vol 26, Iss 11, p 3348 (2021)
Since neurodevelopmental disorders (NDDs) influence more than 3% of children worldwide, there has been intense investigation to understand the etiology of disorders and develop treatments. Although there are drugs such as aripiprazole, risperidone, a
Externí odkaz:
https://doaj.org/article/c654512819cc4a7a893771accc66d6d6
Autor:
Jieon Lee, Kairui Feng, Denise S. Conti, Ross Walenga, Michael Wientjes, Hezhen Wang, Bryan Newman, Liangfeng Han, Sneha Dhapare, Elizabeth Bielski, Andrew Babiskin, Fang Wu, Mark Donnelly, Myong‐Jin Kim, Wenlei Jiang, Markham C. Luke, Lanyan Fang, Liang Zhao
Publikováno v:
Clinical Pharmacology & Therapeutics. 112:982-989
Herein, we present the US Food and Drug Administration (FDA) Office of Research and Standards' current thinking, challenges, and opportunities for comparative clinical endpoint bioequivalence (BE) studies of orally inhaled drug products (OIDPs). Give